FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

395764001: Lacidipine (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1469704012 Lacidipine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1489406016 Lacidipine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
819661000172110 lacidipine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lacidipine (substance) Is a Calcium channel blocker false Inferred relationship Some
Lacidipine (substance) Is a Dihydropyridine derivative calcium channel blocker true Inferred relationship Some
Lacidipine (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Calcium channel blocker (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Lacidipine adverse reaction Causative agent (attribute) True Lacidipine (substance) Inferred relationship Some 1
Allergy to lacidipine Causative agent (attribute) False Lacidipine (substance) Inferred relationship Some
Product containing lacidipine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lacidipine (substance) Inferred relationship Some 1
Lacidipine 2 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lacidipine (substance) Inferred relationship Some
Lacidipine 4 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lacidipine (substance) Inferred relationship Some
Allergy to lacidipine Causative agent (attribute) True Lacidipine (substance) Inferred relationship Some 1
Lacidipine 2 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lacidipine (substance) Inferred relationship Some 1
Lacidipine 2 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Lacidipine (substance) Inferred relationship Some 1
Lacidipine 4 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lacidipine (substance) Inferred relationship Some 1
Lacidipine 4 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Lacidipine (substance) Inferred relationship Some 1
Lacidipine 2 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Lacidipine (substance) Inferred relationship Some 1
Lacidipine 4 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Lacidipine (substance) Inferred relationship Some 1
Product containing lacidipine in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lacidipine (substance) Inferred relationship Some 1
Product containing only lacidipine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lacidipine (substance) Inferred relationship Some 1
Product containing only lacidipine in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lacidipine (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start